These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 9412209

  • 61. In vitro activity, pharmacokinetics, clinical efficacy, safety and pharmacoeconomics of ceftriaxone compared with third and fourth generation cephalosporins: review.
    Bijie H, Kulpradist S, Manalaysay M, Soebandrio A.
    J Chemother; 2005 Feb; 17(1):3-24. PubMed ID: 15828439
    [Abstract] [Full Text] [Related]

  • 62. Comparative non-blind trial of ceftriaxone and gentamicin in the treatment of complicated urinary tract infections.
    Lentini M, Castiello G, Scorza C, Calvosa F.
    J Int Med Res; 1982 Feb; 10(3):166-78. PubMed ID: 6284564
    [Abstract] [Full Text] [Related]

  • 63. Ceftriaxone: therapeutic results in various infections and kinetic studies.
    Giamarellou HJ, Tsagarakis J, Petrikkos G, Mavroudis K, Veldekis D, Daikos GK.
    Arzneimittelforschung; 1984 Feb; 34(3):321-5. PubMed ID: 6329238
    [Abstract] [Full Text] [Related]

  • 64. Cefepime for prophylaxis of infections in the surgery of cholelithiasis. Results of a multicentric comparative trial.
    Del Rio P, Vellone M, Fragapane P, di Millo M, Mazzitelli R, Allegri C, Nuzzo G, Sianesi M.
    Acta Biomed; 2008 Apr; 79(1):23-7. PubMed ID: 18551818
    [Abstract] [Full Text] [Related]

  • 65.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 66.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 67.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 68. Cefotaxime vs nafcillin and tobramycin for the treatment of serious infection. Comparative cost-effectiveness.
    Moore RD, Smith CR, Holloway JJ, Lietman PS.
    Arch Intern Med; 1986 Jun; 146(6):1153-7. PubMed ID: 3087307
    [Abstract] [Full Text] [Related]

  • 69. [Cefixime versus amoxicillin plus netilmicin in the treatment of community-acquired non-complicated acute pyelonephritis].
    Moreno-Martínez A, Mensa J, Martínez JA, Marco F, Vila J, Almela M, García San Miguel J, Soriano E.
    Med Clin (Barc); 1998 Oct 31; 111(14):521-4. PubMed ID: 9859076
    [Abstract] [Full Text] [Related]

  • 70.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 71.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 72.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 73.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 74.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 75. Complicated urinary tract infections treated with cefuroxime or cefazolin: a comparative study.
    Iversen P, Madsen PO.
    Clin Ther; 1981 Oct 31; 4(4):302-7. PubMed ID: 7037184
    [Abstract] [Full Text] [Related]

  • 76. Reduction of hospital costs and administration of prophylactic antibiotherapy in gynecological surgery.
    Hell-Türler KT.
    Isr J Med Sci; 1992 Oct 31; 28(10):751. PubMed ID: 1399513
    [No Abstract] [Full Text] [Related]

  • 77.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 78. Once-daily intravenous cefazolin plus oral probenecid is equivalent to once-daily intravenous ceftriaxone plus oral placebo for the treatment of moderate-to-severe cellulitis in adults.
    Grayson ML, McDonald M, Gibson K, Athan E, Munckhof WJ, Paull P, Chambers F.
    Clin Infect Dis; 2002 Jun 01; 34(11):1440-8. PubMed ID: 12015689
    [Abstract] [Full Text] [Related]

  • 79. A multicenter, open comparative study of parenteral cefotaxime and ceftriaxone in the treatment of nosocomial lower respiratory tract infections.
    Garber GE, Auger P, Chan RM, Conly JM, Shafran SD, Gerson M.
    Diagn Microbiol Infect Dis; 1992 Jan 01; 15(1):85-8. PubMed ID: 1730189
    [Abstract] [Full Text] [Related]

  • 80.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.